EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emerging probiotics: future therapeutics for human gut health

Sylvia H Duncan iD, Carlos Sabater iD

FEMS Microbiology Ecology · 14.07.2025 · 101 (8)

DOI: 10.1093/femsec/fiaf077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEMS Microbiology Ecology, online erschienen am 25.07.2025. Verfasst von Sylvia H Duncan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Bacteria, Gastrointestinal Tract. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rural and Environment Science and Analytical Services Division, Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The microbial communities that colonize the human large intestine can influence many aspects of health and Bacillota strains, in particular, have been proposed as next-generation probiotics. Of note are strains including fibre-degraders, butyrate producers, lactate producers and utilizers, and other beneficial metabolic activities that are important for health. To illustrate the potential applications of colonic bacteria to design novel prebiotic formulations, a comparative genomics analysis of 16 bacterial strains isolated from the human gut was performed. This analysis revealed a high number of carbohydrate-active enzymes (CAZymes) in the genome sequences of understudied Lachnospiraceae and Oscillospiraceae members including Roseburia intestinalis L1-82, Roseburia faecis M72/1, Butyrivibrio fibrisolvens 16-4, and Ruminococcus bicirculans 80/3, ranging from 32 to 56 CAZymes across different strains. These strains showed complementary enzymatic profiles covering a wide range of different activities required to degrade prebiotic substrates derived from vegetable sources such as arabino- and xylo-oligosaccharides and pectic-oligosaccharides. These metabolic differences highlight the potential of these strains to cross feed and to allow the design novel probiotic consortia for microbiota-oriented interventions that could target specific disease conditions. These bacterial strains are, however, strict anaerobes and therefore special measures may need to be put in place to overcome these limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsGastrointestinal MicrobiomeBacteriaGastrointestinal TractHumansPrebioticsGenome, Bacterial

Stichwörter der Autor:innen

EubacteriumFaecalibacteriumRoseburiaRuminococcusnext-generation probiotics

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK.

ORCID-Profile: Sylvia H Duncan, Carlos Sabater

Förderung

  • Rural and Environment Science and Analytical Services Division
  • Engineering and Physical Sciences Research Council

Zitieren

APA

Duncan, S. H., & Sabater, C. (2025). Emerging probiotics: future therapeutics for human gut health. FEMS Microbiology Ecology, 101(8). https://doi.org/10.1093/femsec/fiaf077

Vancouver

Duncan SH, Sabater C. Emerging probiotics: future therapeutics for human gut health. FEMS Microbiology Ecology. 2025;101(8). doi:10.1093/femsec/fiaf077

BibTeX
@article{Duncan2025,
  author = {Duncan, Sylvia H and Sabater, Carlos},
  title = {Emerging probiotics: future therapeutics for human gut health},
  journal = {FEMS Microbiology Ecology},
  year = {2025},
  volume = {101},
  number = {8},
  doi = {10.1093/femsec/fiaf077}
}
Kostenlos starten →